Global Micro RNA Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Albany, New York (PRWEB) December 21, 2013 -- Micro-RNA is a small non-coding RNA molecule which is a vital component of genetic regulation. Set of micro-RNAs are present in plants and animals functioning in gene expression process. They are involved in the normal functioning of the eukaryotic cells. Biogenesis of micro-RNA is the basis for RNA interference drug discovery and research in therapeutics. Micro-RNAs are likely to be involved in biological processes by affecting the gene regulation. Research and development of micro-RNA based therapies are recently being exploited due to the implication of unusually expressed micro-RNA in numerous disorders such as cancer, cardiovascular diseases and HIV infections.
Browse the full report with request TOC at
http://www.transparencymarketresearch.com/micro-rna-market.html
The global micro-RNA market if categorized into:
Applications
Research
Diagnosis
Therapeutics
Technology
Purification
Labeling
Linear amplification
Microarrays
qRT-PCR
Inhibition
Globally, North America and Europe are the leading regions with booming micro-RNA market. Emerging economies of Asia such as India, Japan, China and Singapore as well as the Middle East and Latin American countries are also expected to show soaring progress in the growth of micro-RNA market.
Browse Pharmaceutical Blog: http://pharmaceuticalresearchreport.blogspot.com/
One of the key factors driving the global micro-RNA market is provision of large scale funding by public and private sectors. Other factors responsible for the growth of this market are growing interest of pharmaceutical and biotechnological companies in conducting research on micro-RNAs and identification of micro-RNA role in different disease classes.
Related Report : Pharmacovigilance Market
http://www.transparencymarketresearch.com/pharmacovigilance-market.html
Some of the major players contributing to the global micro-RNA market comprises Access Pharmaceuticals, Agilent Technologies, Astrazeneca Pharmaceuticals LP, Benitec Biopharma Limited, Calando Pharmaceuticals, Inc., Covance, Inc., Eli Lilly and Co., F. Hoffman-La Roche AG, Illumina, Inc., Novartis International AG, Senesco Technologies, Inc., Sirnaomics, Inc., Tekmira Pharmaceuticals Corporation and Thermo Fisher Scientific, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Browse Blog: http://www.tmrblog.com/
Browse all Market Research reports: http://marketsandresearch.blogspot.com/
Sheela AK, Transparency Market Research, http://www.transparencymarketresearch.com, +1 518-618-1030, [email protected]
Share this article